Back to Search
Start Over
Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis.
- Source :
-
Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2011; Vol. 66 (8), pp. 1401-6. - Publication Year :
- 2011
-
Abstract
- Introduction: Epstein-Barr virus exposure appears to be an environmental trigger for rheumatoid arthritis that interacts with other risk factors. Relationships among anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status have been observed in patients with rheumatoid arthritis from different populations.<br />Objective: To perform an association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status in Brazilian patients with rheumatoid arthritis.<br />Methods: In a case-control study, 140 rheumatoid arthritis patients and 143 healthy volunteers who were matched for age, sex, and ethnicity were recruited. Anti-Epstein-Barr nuclear antigen-1 antibodies and anti-cyclic citrullinated peptide antibodies were examined using an enzyme-linked immunosorbent assay, and shared epitope alleles were identified by genotyping. Smoking information was collected from all subjects. A comparative analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope, and smoking status was performed in the patient group. Logistic regression analysis models were used to analyze the risk of rheumatoid arthritis.<br />Results: Anti-Epstein-Barr nuclear antigen-1 antibodies were not associated with anti-cyclic citrullinated peptide antibodies, shared epitope alleles, or smoking status. Anti-cyclic citrullinated peptide antibody positivity was significantly higher in smoking patients with shared epitope alleles (OR = 3.82). In a multivariate logistic regression analysis using stepwise selection, only anti-cyclic citrullinated peptide antibodies were found to be independently associated with rheumatoid arthritis (OR = 247.9).<br />Conclusion: Anti-Epstein-Barr nuclear antigen-1 antibodies did not increase the risk of rheumatoid arthritis and were not associated with the rheumatoid arthritis risk factors studied. Smoking and shared epitope alleles were correlated with anti-cyclic citrullinated peptide-antibody-positive rheumatoid arthritis. Of the risk factors, only anticyclic citrullinated peptides antibodies were independently associated with rheumatoid arthritis susceptibility.
- Subjects :
- Adult
Aged
Aged, 80 and over
Alleles
Antibodies, Viral blood
Arthritis, Rheumatoid genetics
Arthritis, Rheumatoid immunology
Autoantibodies blood
Case-Control Studies
Enzyme-Linked Immunosorbent Assay
Epitopes blood
Epitopes immunology
Female
Genotype
Humans
Male
Middle Aged
Risk Factors
Arthritis, Rheumatoid etiology
Epstein-Barr Virus Infections complications
Epstein-Barr Virus Nuclear Antigens blood
Peptides, Cyclic immunology
Smoking adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1980-5322
- Volume :
- 66
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Clinics (Sao Paulo, Brazil)
- Publication Type :
- Academic Journal
- Accession number :
- 21915491
- Full Text :
- https://doi.org/10.1590/s1807-59322011000800016